![Bryan Mcmichael](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Mcmichael
Director of Finance/CFO at
COHERUS ONCOLOGY, INC.
Net worth: 161 821 $ as of 30/09/2026
Profile
Bryan Mcmichael is Chief Financial Officer at Coherus Oncology, Inc. since 2024.
Mr. Mcmichael was Executive Director at Gilead Sciences, Inc. from 2016 to 2021.
Mr. Mcmichael completed undergraduate studies at San Diego State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/05/2026 | 133,736 ( 0.09% ) | 161 821 $ | 30/09/2026 |
Bryan Mcmichael active positions
| Companies | Position | Start |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Director of Finance/CFO | 08/12/2023 |
Former positions of Bryan Mcmichael
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Director/Board Member | 01/03/2021 |
Education of Bryan Mcmichael
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
- Stock Market
- Insiders
- Bryan Mcmichael
